EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Mycobacterium tuberculosis Cell Wall: An Alluring Drug Target for Developing Newer Anti‐ TB Drugs—A Perspective

Monica Chauhan, Rahul Barot, Rasana Yadav, Karan Joshi, Sadaf Mirza, Rupesh Chikhale, Vijay Kumar Srivastava, Mange Ram Yadav iD, Prashant R Murumkar iD

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14612 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Monica Chauhan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Kalabhavan Campus, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India. Hauptthemen laut MEDLINE: Cell Wall, Antitubercular Agents, Mycobacterium tuberculosis, Bacterial Proteins. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 196 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Mycobacterium cell wall is a capsule‐like structure comprising of various layers of biomolecules such as mycolic acid, peptidoglycans, and arabinogalactans, which provide the Mycobacteria a sort of cellular shield. Drugs like isoniazid, ethambutol, cycloserine, delamanid, and pretomanid inhibit cell wall synthesis by inhibiting one or the other enzymes involved in cell wall synthesis. Many enzymes present across these layers serve as potential targets for the design and development of newer anti‐TB drugs. Some of these targets are currently being exploited as the most druggable targets like DprE1, InhA, and MmpL3. Many of the anti‐TB agents present in clinical trials inhibit cell wall synthesis. The present article covers a systematic perspective of developing cell wall inhibitors targeting various enzymes involved in cell wall biosynthesis as potential drug candidates for treating Mtb infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell WallAntitubercular AgentsMycobacterium tuberculosisBacterial ProteinsHumansTuberculosisOxidoreductasesMycolic AcidsAlcohol OxidoreductasesMembrane Transport Proteins

Stichwörter der Autor:innen

DprE1InhAMmpL3anti‐TB agentsdrug resistancemycobacterianon‐tuberculous mycobacteriatuberculosis

Substanzen

Antitubercular AgentsBacterial ProteinsOxidoreductasesInhA protein, MycobacteriumMmpL3 protein, Mycobacterium tuberculosisDprE1 protein, Mycobacterium tuberculosisMycolic AcidsAlcohol OxidoreductasesMembrane Transport Proteins

Autor:innen und Institutionen

  • Faculty of Pharmacy, Kalabhavan Campus, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India.
  • The Cambridge Crystallography Data Center, Cambridge, UK.
  • School of Pharmacy, University College London, London, UK.
  • The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India.
  • Centre of Research for Development, Parul University, Vadodara, Gujarat, India.

ORCID-Profile: Mange Ram Yadav, Prashant R Murumkar

Zitieren

APA

Chauhan, M., Barot, R., Yadav, R., Joshi, K., Mirza, S., Chikhale, R., Srivastava, V. K., Yadav, M. R., & Murumkar, P. R. (2024). The Mycobacterium tuberculosis Cell Wall: An Alluring Drug Target for Developing Newer Anti‐ TB Drugs—A Perspective. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14612

Vancouver

Chauhan M, Barot R, Yadav R, Joshi K, Mirza S, Chikhale R, et al. The Mycobacterium tuberculosis Cell Wall: An Alluring Drug Target for Developing Newer Anti‐ TB Drugs—A Perspective. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14612

BibTeX
@article{Chauhan2024,
  author = {Chauhan, Monica and Barot, Rahul and Yadav, Rasana and Joshi, Karan and Mirza, Sadaf and Chikhale, Rupesh and Srivastava, Vijay Kumar and Yadav, Mange Ram and Murumkar, Prashant R},
  title = {The Mycobacterium tuberculosis Cell Wall: An Alluring Drug Target for Developing Newer Anti‐ TB Drugs—A Perspective},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14612}
}
Kostenlos starten →